Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ewa Robak

Showing results (1-10 of 71) with videos related to

Pageof 8
Sort By:
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 25, 2010
New anti-CD20 monoclonal antibodies for the treatment of B-cell lymphoid malignanciesTadeusz Robak, Ewa Robak
Postepy Higieny I Medycyny Doswiadczalnej (Online)|December 23, 2014
[Pro-angiogenic cytokines in systemic sclerosis]Ewa Robak, Zofia Gerlicz
Postepy Higieny I Medycyny Doswiadczalnej (Online)|October 23, 2010
[Rosacea]Ewa Robak, Lilianna Kulczycka
Expert Opinion on Investigational Drugs|May 23, 2012
Tyrosine kinase inhibitors as potential drugs for B-cell lymphoid malignancies and autoimmune disordersTadeusz Robak, Ewa Robak
Cancers|February 13, 2026
Cutaneous Adverse Effects in Patients Treated with BTK InhibitorsEwa Robak, Tadeusz Robak
Current Drug Targets|January 20, 2009
Monoclonal antibodies in the treatment of systemic lupus erythematosusEwa Robak, Tadeusz Robak
Leukemia & Lymphoma|May 10, 2007
Skin lesions in chronic lymphocytic leukemiaEwa Robak, Tadeusz Robak
Journal of Clinical Medicine|May 28, 2022
Bruton's Kinase Inhibitors for the Treatment of Immunological Diseases: Current Status and PerspectivesEwa Robak, Tadeusz Robak
Expert Opinion on Investigational Drugs|April 9, 2014
Current Phase II antibody-drug conjugates for the treatment of lymphoid malignanciesTadeusz Robak, Ewa Robak
Przeglad Lekarski|May 8, 2013
[Connective tissue diseases during pregnancy - therapeutic aspect. Part 1: SLE, antiphosholipid syndrome]Małgorzata Putała-Pośpiech, Ewa Robak
Pageof 8

Showing results (1-10 of 71) with videos related to

Sort By:
Pageof 8
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 25, 2010
New anti-CD20 monoclonal antibodies for the treatment of B-cell lymphoid malignanciesTadeusz Robak, Ewa Robak
Postepy Higieny I Medycyny Doswiadczalnej (Online)|December 23, 2014
[Pro-angiogenic cytokines in systemic sclerosis]Ewa Robak, Zofia Gerlicz
Postepy Higieny I Medycyny Doswiadczalnej (Online)|October 23, 2010
[Rosacea]Ewa Robak, Lilianna Kulczycka
Expert Opinion on Investigational Drugs|May 23, 2012
Tyrosine kinase inhibitors as potential drugs for B-cell lymphoid malignancies and autoimmune disordersTadeusz Robak, Ewa Robak
Cancers|February 13, 2026
Cutaneous Adverse Effects in Patients Treated with BTK InhibitorsEwa Robak, Tadeusz Robak
Current Drug Targets|January 20, 2009
Monoclonal antibodies in the treatment of systemic lupus erythematosusEwa Robak, Tadeusz Robak
Leukemia & Lymphoma|May 10, 2007
Skin lesions in chronic lymphocytic leukemiaEwa Robak, Tadeusz Robak
Journal of Clinical Medicine|May 28, 2022
Bruton's Kinase Inhibitors for the Treatment of Immunological Diseases: Current Status and PerspectivesEwa Robak, Tadeusz Robak
Expert Opinion on Investigational Drugs|April 9, 2014
Current Phase II antibody-drug conjugates for the treatment of lymphoid malignanciesTadeusz Robak, Ewa Robak
Przeglad Lekarski|May 8, 2013
[Connective tissue diseases during pregnancy - therapeutic aspect. Part 1: SLE, antiphosholipid syndrome]Małgorzata Putała-Pośpiech, Ewa Robak
Pageof 8